| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Exphox WebRadar. It has been classified as problematic. The affected element is an unknown function. Performing a manipulation results in cross site scripting. This vulnerability is known as CVE-2016-8922. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability, which was classified as problematic, was found in Exphox WebRadar (unknown version). This affects an unknown code block. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Exphox WebRadar is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
The bug was discovered 11/18/2016. The weakness was published 02/01/2017 (Website). The advisory is shared at ibm.com. This vulnerability is uniquely identified as CVE-2016-8922 since 10/25/2016. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The vulnerability was handled as a non-public zero-day exploit for at least 75 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 94413†). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/25/2016 🔍11/18/2016 🔍
11/18/2016 🔍
02/01/2017 🔍
02/01/2017 🔍
02/02/2017 🔍
08/31/2020 🔍
Sources
Advisory: ibm.comStatus: Not defined
Confirmation: 🔍
CVE: CVE-2016-8922 (🔍)
GCVE (CVE): GCVE-0-2016-8922
GCVE (VulDB): GCVE-100-96465
SecurityFocus: 94413 - IBM Web Content Manager Production Analytics Unspecified Cross Site Scripting Vulnerability
OSVDB: - CVE-2016-8922 - Ephox - WebRadar - Cross-Site Scripting Issue
Entry
Created: 02/02/2017 11:56Updated: 08/31/2020 18:57
Changes: 02/02/2017 11:56 (55), 08/31/2020 18:57 (6)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.